Related Experiment Video

Updated: May 9, 2026

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors
07:57

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors

Published on: January 20, 2023

Inhibition of HSP90 molecular chaperones: moving into the clinic

Rocio Garcia-Carbonero1, Amancio Carnero, Luis Paz-Ares

  • 1Laboratorio de Oncología Molecular y Nuevas Terapias, Instituto de Biomedicina de Sevilla (HUVR/CSIC/Universidad de Sevilla), Sevilla, Spain.

The Lancet. Oncology
|July 31, 2013
PubMed

Insights

Heat shock protein 90 (HSP90) inhibitors target oncogenic proteins crucial for cancer cell survival. This review explores their development as anticancer agents, showing promise in specific solid tumors and blood cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Heat shock protein 90 (HSP90) is a vital molecular chaperone.
  • HSP90 stabilizes numerous client proteins, including oncogenes like tyrosine kinases and transcription factors.
  • Inhibition of HSP90 leads to the degradation of these client proteins via the ubiquitin-proteasome pathway.

Purpose of the Study:

  • To review the current clinical development status of HSP90 inhibitors as anticancer agents.
  • To discuss various classes of HSP90 inhibitors, including geldanamycin, resorcinol derivatives, and purine analogues.
  • To explore novel strategies and future perspectives for optimizing HSP90 inhibitor therapy.

Main Methods:

  • Review of existing literature on HSP90 inhibitors in clinical development.
  • Analysis of promising results in specific cancer types.
  • Discussion of different chemical classes of HSP90 inhibitors.

Main Results:

  • HSP90 inhibitors demonstrate potential by downregulating multiple oncogenic pathways simultaneously.
  • Early clinical trials show promising results in molecularly defined subgroups, such as ALK-rearranged non-small-cell lung cancer and HER2-amplified breast cancer.
  • Positive outcomes have also been observed in hematological malignancies like multiple myeloma.

Conclusions:

  • HSP90 inhibitors represent a promising new class of anticancer drugs.
  • Their ability to target multiple oncogenic pathways offers a unique therapeutic strategy.
  • Further research and novel strategies are needed to optimize their therapeutic potential and clinical application.

More Related Videos

Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay06:51

Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay

Published on: July 21, 2021

Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology09:39

Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology

Published on: March 31, 2022

Related Concept Videos

Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...